Evaluating Newly Approved Drugs for Multidrug-resistant TB

NCT02754765 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

754

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Multidrug-Resistant
Infection, Bacterial
Pulmonary Tuberculoses

Interventions

DRUG: Bedaquiline
DRUG: Delamanid
DRUG: Clofazimine
DRUG: Levofloxacin
DRUG: Moxifloxacin
DRUG: Linezolid
DRUG: Pyrazinamide
DRUG: Control arm MDR-TB regimen, consistent with WHO guidelines

Sponsor

Médecins Sans Frontières, France

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]